Skip to results
Modify your search
NARROW
1-20 of 29
Authors: Marc Antoine Valantin
Journal Article
Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugs Get access
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 3, March 2025, Pages 697–700, https://doi.org/10.1093/jac/dkae458
Published: 20 December 2024
Journal Article
Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir Free
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 7, July 2024, Pages 1706–1707, https://doi.org/10.1093/jac/dkae115
Published: 17 April 2024
Journal Article
More HIV-1 RNA detected and quantified with the Cobas 6800 system in patients on antiretroviral therapy Free
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 8, August 2022, Pages 2251–2256, https://doi.org/10.1093/jac/dkac174
Published: 31 May 2022
Journal Article
Presence of HIV-1 G-to-A mutations linked to APOBEC editing is more prevalent in non-B HIV-1 subtypes and is associated with lower HIV-1 reservoir Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 8, August 2021, Pages 2148–2152, https://doi.org/10.1093/jac/dkab123
Published: 30 April 2021
Journal Article
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 7, July 2021, Pages 1893–1897, https://doi.org/10.1093/jac/dkab108
Published: 14 April 2021
Journal Article
No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 6, June 2021, Pages 1553–1557, https://doi.org/10.1093/jac/dkab064
Published: 10 March 2021
Journal Article
Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM Free
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 7, July 2020, Pages 1961–1968, https://doi.org/10.1093/jac/dkaa091
Published: 19 April 2020
Journal Article
Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial) Free
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 7, July 2020, Pages 1943–1949, https://doi.org/10.1093/jac/dkaa090
Published: 07 April 2020
Journal Article
Efficacy of intermittent short cycles of integrase inhibitor-based maintenance ART in virologically suppressed HIV patients Free
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1321–1323, https://doi.org/10.1093/jac/dkz555
Published: 16 January 2020
Journal Article
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study—authors’ response Free
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 12, December 2020, Pages 3699–3700, https://doi.org/10.1093/jac/dkaa341
Published: 20 September 2019
Journal Article
Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study Free
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 9, September 2019, Pages 2716–2722, https://doi.org/10.1093/jac/dkz255
Published: 04 July 2019
Journal Article
EDITOR'S CHOICE
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study Free
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 9, September 2019, Pages 2742–2751, https://doi.org/10.1093/jac/dkz224
Published: 03 July 2019
Journal Article
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations Free
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 7, July 2019, Pages 2019–2023, https://doi.org/10.1093/jac/dkz151
Published: 03 May 2019
Journal Article
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation Free
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 5, May 2017, Pages 1537–1539, https://doi.org/10.1093/jac/dkw571
Published: 14 January 2017
Journal Article
HIV-1 diagnosis with unquantifiable viraemia: don’t be naive, look for antiretroviral drugs Free
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 630–632, https://doi.org/10.1093/jac/dkw474
Published: 20 December 2016
Journal Article
EDITOR'S CHOICE
Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial) Free
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 12, December 2015, Pages 3339–3344, https://doi.org/10.1093/jac/dkv280
Published: 22 September 2015
Journal Article
Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 8, August 2015, Pages 2347–2353, https://doi.org/10.1093/jac/dkv099
Published: 28 April 2015
Journal Article
Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 8, August 2015, Pages 2418–2420, https://doi.org/10.1093/jac/dkv113
Published: 26 April 2015
Journal Article
Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 7, July 2015, Pages 2108–2120, https://doi.org/10.1093/jac/dkv084
Published: 21 April 2015
Journal Article
New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 8, August 2014, Pages 2118–2122, https://doi.org/10.1093/jac/dku095
Published: 07 April 2014
